Pulse Biosciences, Inc. Retained Earnings
Pulse Biosciences, Inc. (PLSE) had Retained Earnings of -$506.52 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$506.52M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$481.86M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$463.28M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$445.85M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$506.52M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$481.86M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$463.28M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$445.85M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | -$426.46M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | -$407.30M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$390.50M 10-K · filed 2026-02-19 | |
| 2024-09-30 | -$371.12M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | -$358.44M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | -$347.05M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | -$336.92M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$324.98M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$314.42M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$304.51M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$294.70M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$285.51M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$267.47M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | -$253.47M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | -$336.92M 10-Q · filed 2024-10-30 | -$236.20M 10-K · filed 2022-03-31 |
| 2021-09-30 | -$220.78M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$206.50M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | -$191.18M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | -$172.54M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$158.79M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$145.89M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | -$134.56M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$122.69M 10-K · filed 2021-03-12 | |
| 2019-09-30 | -$108.90M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$97.16M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$85.80M 10-Q · filed 2019-05-03 | |
| 2018-12-31 | -$75.72M 10-K · filed 2020-03-16 | |
| 2018-09-30 | -$66.77M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | -$56.00M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | -$46.84M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | -$38.17M 10-K · filed 2019-03-14 | |
| 2017-09-30 | -$29.47M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | -$21.98M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | -$15.80M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | -$12.61M 10-K · filed 2018-03-16 | |
| 2016-09-30 | -$9.80M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$7.03M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | -$4.77M 10-Q · filed 2016-06-27 | |
| 2015-12-31 | -$3.09M 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |